Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8Melanoma 6Colitis, Ulcerative 6Inflammatory Bowel Diseases 5Crohn Disease 5Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Colitis 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1

Interventions

Nutrition Assessment 3Transcranial Direct Current Stimulation 2urinastatin 1tocilizumab 1rimabotulinumtoxinB 1X-Rays 1Vitamin B 6 1Vitamin B 12 1Thrombectomy 1Standard of Care 1Saline Solution 1Rosuvastatin Calcium 1Resistance Training 1Practice Guidelines as Topic 1Phenylephrine 1Palliative Care 1Norepinephrine 1Neuropsychological Tests 1Music Therapy 1Massage 1Lysine Acetyltransferase 5 1Infliximab 1Immunoglobulin G 1Hematologic Tests 1Folic Acid 1Extracorporeal Shockwave Therapy 1Exergaming 1Enoxaparin 1Disulfides 1Dialectical Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stroke × Infliximab × Clear all
NCT02638701 2025-07-08

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

University of California, San Francisco

Phase 1/2 Recruiting
8 enrolled

Aneurysm, Vasculitis, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡